APPLIED DNA SCIENCES INC (APDN) Stock Cash Flow
NASDAQ:APDN - Nasdaq - US03815U4094 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.63M | -7.09M | -10.02M | -8.27M | -14.28M | |||
| Depreciation Amortization | 456.01K | 696.43K | 1.36M | 1.29M | 844.40K | |||
| Change In Working Capital | -1.03M | -1.14M | 2.45M | 954.60K | -3.62M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 28.30K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | -4.08M | -6.18M | -3.60K | -2.95M | 3.66M | |||
| OPERATING CASH FLOW | -13.28M | -13.71M | -6.22M | -8.98M | -13.39M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -407.90K | -1.14M | -489.60K | -2.55M | |||
| Other Investing Activity | N/A | 0.00 | 45.00K | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -407.90K | -1.10M | -489.60K | -2.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -1.67M | |||
| Stock Issued/Repurchased | 19.66M | 13.40M | 0.00 | 18.13M | 16.37M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 19.74M | 13.40M | 0.00 | 18.13M | 14.70M | |||
| CHANGE IN CASH | 5.94M | -720.70K | -7.31M | 8.66M | -1.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.28M | -13.71M | -6.22M | -8.98M | -13.39M | |||
| Capital Expenditure | N/A | -407.90K | -1.14M | -489.60K | -2.55M | |||
| FREE CASH FLOW | -13.80M | -14.12M | -7.36M | -9.47M | -15.94M | |||
All data in USD